Abstract
This narrative review provides a broad perspective on immature control of breathing, which is universal in infants born premature. The degree of immaturity and severity of clinical symptoms are inversely correlated with gestational age. This immaturity presents as prolonged apneas with associated bradycardia or desaturation, or brief respiratory pauses, periodic breathing, and intermittent hypoxia. These manifestations are encompassed within the clinical diagnosis of apnea of prematurity, but there is no consensus on minimum criteria required for diagnosis. Common treatment strategies include caffeine and noninvasive respiratory support, but other therapies have also been advocated with varying effectiveness. There is considerable variability in when and how to initiate and discontinue treatment. There are significant knowledge gaps regarding effective strategies to quantify the severity of clinical manifestations of immature breathing, which prevent us from better understanding the long-term potential adverse outcomes, including neurodevelopment and sudden unexpected infant death.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others
References
Yiallourou SR, Witcombe NB, Sands SA, Walker AM, Horne RS. The development of autonomic cardiovascular control is altered by preterm birth. Early Hum Dev. 2013;89:145–52.
Martin RJ, Wilson CG. Apnea of prematurity. Compr Physiol. 2012;2:2923–31.
Poets CF. Apnea of prematurity: what can observational studies tell us about pathophysiology? Sleep Med. 2010;11:701–7.
Lorch SA, Srinivasan L, Escobar GJ. Epidemiology of apnea and bradycardia resolution in premature infants. Pediatrics. 2011;128:e366–73.
Dobson NR, Thompson MW, Hunt CE. Control of breathing: maturation and associated clinical disorders. In: JP Boardman AG, J Ramasethu, editors. 8th ed. of Avery and MacDonald’s Neonatology Pathophysiology and Management of the Newborn: Wolters Kluwer Health; 2021.
Henderson-Smart DJ. The effect of gestational age on the incidence and duration of recurrent apnoea in newborn babies. Aust Paediatr J. 1981;17:273–6.
Barrington K, Finer N. The natural history of the appearance of apnea of prematurity. Pediatr Res. 1991;29:372–5.
Di Fiore JM, Poets CF, Gauda E, Martin RJ, MacFarlane P. Cardiorespiratory events in preterm infants: etiology and monitoring technologies. J Perinatol. 2016;36:165–71.
Di Fiore JM, Martin RJ, Gauda EB. Apnea of prematurity—perfect storm. Respir Physiol Neurobiol. 2013;189:213–22.
Ramanathan R, Corwin MJ, Hunt CE, Lister G, Tinsley LR, Baird T, et al. Cardiorespiratory events recorded on home monitors: Comparison of healthy infants with those at increased risk for SIDS. JAMA. 2001;285:2199–207.
Hunt CE, Corwin MJ, Lister G, Weese-Mayer DE, Ward SL, Tinsley LR, et al. Precursors of cardiorespiratory events in infants detected by home memory monitor. Pediatr Pulmonol. 2008;43:87–98.
Fairchild K, Mohr M, Paget-Brown A, Tabacaru C, Lake D, Delos J, et al. Clinical associations of immature breathing in preterm infants: part 1-central apnea. Pediatr Res. 2016;80:21–7.
Marshall AP, Lim K, Ali SK, Gale TJ, Dargaville PA. Physiological instability after respiratory pauses in preterm infants. Pediatr Pulmonol. 2019;54:1712–21.
Al-Matary A, Kutbi I, Qurashi M, Khalil M, Alvaro R, Kwiatkowski K, et al. Increased peripheral chemoreceptor activity may be critical in destabilizing breathing in neonates. Semin Perinatol. 2004;28:264–72.
Patel M, Mohr M, Lake D, Delos J, Moorman JR, Sinkin RA, et al. Clinical associations with immature breathing in preterm infants: part 2-periodic breathing. Pediatr Res. 2016;80:28–34.
Seppä-Moilanen M, Andersson S, Rantakari K, Mikkola K, Kirjavainen T. Caffeine and supplemental oxygen effectively suppress periodic breathing with only minor effects during long episodes of apnoea in preterm infants. Acta Paediatr. 2019;108:443–51.
MacFarlane PM, Ribeiro AP, Martin RJ. Carotid chemoreceptor development and neonatal apnea. Respir Physiol Neurobiol. 2013;185:170–6.
Hunt CE, Corwin MJ, Weese-Mayer DE, Ward SL, Ramanathan R, Lister G, et al. Longitudinal assessment of hemoglobin oxygen saturation in preterm and term infants in the first six months of life. J Pediatr. 2011;159:377–83.e1.
Di Fiore JM, Bloom JN, Orge F, Schutt A, Schluchter M, Cheruvu VK, et al. A higher incidence of intermittent hypoxemic episodes is associated with severe retinopathy of prematurity. J Pediatr. 2010;157:69–73.
Cailleau L, Weber R, Cabon S, Flamant C, Roué J-M, Favrais G, et al. Quiet sleep organization of very preterm infants is correlated with postnatal maturation. Front Pediatr. 2020;8:559658.
Bloch-Salisbury E, Hall MH, Sharma P, Boyd T, Bednarek F, Paydarfar D. Heritability of apnea of prematurity: a retrospective twin study. Pediatrics. 2010;126:e779–87.
Kumral A, Tuzun F, Yesilirmak DC, Duman N, Ozkan H. Genetic basis of apnoea of prematurity and caffeine treatment response: role of adenosine receptor polymorphisms: genetic basis of apnoea of prematurity. Acta Paediatr. 2012;101:e299–303.
He X, Qiu JC, Lu KY, Guo HL, Li L, Jia WW, et al. Therapy for apnoea of prematurity: a retrospective study on effects of standard dose and genetic variability on clinical response to caffeine citrate in Chinese preterm infants. Adv Ther. 2021;38:607–26.
Dobson NR, Hunt CE. Caffeine: an evidence-based success story in VLBW pharmacotherapy. Pediatr Res. 2018;84:333–40.
Henderson-Smart DJ, De Paoli AG. Methylxanthine treatment for apnoea in preterm infants. Cochrane Database Syst Rev. 2010;12:CD000140.
Henderson-Smart DJ, Steer PA. Caffeine versus theophylline for apnea in preterm infants. Cochrane Database Syst Rev. 2010;1:CD000273.
Mayer CA, Haxhiu MA, Martin RJ, Wilson CG. Adenosine A2A receptors mediate GABAergic inhibition of respiration in immature rats. J Appl Physiol. 2006;100:91–7.
Wilson CG, Martin RJ, Jaber M, Abu-Shaweesh J, Jafri A, Haxhiu MA, et al. Adenosine A2A receptors interact with GABAergic pathways to modulate respiration in neonatal piglets. Respir Physiol Neurobiol. 2004;141:201–11.
Aranda JV, Gorman W, Bergsteinsson H, Gunn T. Efficacy of caffeine in treatment of apnea in the low-birth-weight infant. J Pediatr. 1977;90:467–72.
Aranda JV, Turmen T. Methylxanthines in apnea of prematurity. Clin Perinatol. 1979;6:87–108.
Puia-Dumitrescu M, Smith PB, Zhao J, Soriano A, Payne EH, Harper B, et al. Dosing and safety of off-label use of caffeine citrate in premature infants. J Pediatr. 2019;211:27–32.e1.
Brattström P, Russo C, Ley D, Bruschettini M. High-versus low-dose caffeine in preterm infants: a systematic review and meta-analysis. Acta Paediatr. 2019;108:401–10.
Ravichandran S, Chouthai NS, Patel B, Sharma A, Gupte A, Ma MM, et al. Higher daily doses of caffeine lowered the incidence of moderate to severe neurodevelopmental disabilities in very low birth weight infants. Acta Paediatr. 2019;108:430–5.
McPherson C, Neil JJ, Tjoeng TH, Pineda R, Inder TE. A pilot randomized trial of high-dose caffeine therapy in preterm infants. Pediatr Res. 2015;78:198–204.
Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, et al. Caffeine therapy for apnea of prematurity. N Engl J Med. 2006;354:2112–21.
Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, et al. Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med. 2007;357:1893–902.
Schmidt B, Anderson PJ, Doyle LW, Dewey D, Grunau RE, Asztalos EV, et al. Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity. JAMA. 2012;307:275–82.
Gounaris AK, Grivea IN, Baltogianni M, Gounari E, Antonogeorgos G, Kokori F, et al. Caffeine and gastric emptying time in very preterm neonates. J Clin Med. 2020;9:1676.
Ilhan O, Bor M. Effects of caffeine on splanchnic oxygenation in preterm infants. Am J Perinatol. 2020. Epub ahead of print.
Welsh C, Pan J, Belik J. Caffeine impairs gastrointestinal function in newborn rats. Pediatr Res. 2015;78:24–8.
Gillot I, Gouyon JB, Guignard JP. Renal effects of caffeine in preterm infants. Biol Neonate. 1990;58:133–6.
Harer MW, Askenazi DJ, Boohaker LJ, Carmody JB, Griffin RL, Guillet R, et al. Association between early caffeine citrate administration and risk of acute kidney injury in preterm neonates: results from the AWAKEN Study. JAMA Pediatr. 2018;172:e180322.
Ergenekon E, Dalgiç N, Aksoy E, Koç E, Atalay Y. Caffeine intoxication in a premature neonate. Paediatr Anaesth. 2001;11:737–9.
Nakaoka S, Kawasaki Y, Inomata S, Makimoto M, Yoshida T. Caffeine toxicity in a preterm neonate. Pediatr Neonatol. 2017;58:380–1.
Charles BG, Townsend SR, Steer PA, Flenady VJ, Gray PH, Shearman A. Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring. Ther Drug Monit. 2008;30:709–16.
Henderson-Smart DJ, Davis PG. Prophylactic methylxanthines for endotracheal extubation in preterm infants. Cochrane Database Syst Rev. 2010;12:CD000139.
Doyle LW, Ranganathan S, Cheong JLY. Neonatal caffeine treatment and respiratory function at 11 years in children under 1,251 g at birth. Am J Respir Crit Care Med. 2017;196:1318–24.
Davis PG, Schmidt B, Roberts RS, Doyle LW, Asztalos E, Haslam R, et al. Caffeine for apnea of prematurity trial: benefits may vary in subgroups. J Pediatr. 2010;156:382–7.
Nylander Vujovic S, Nava C, Johansson M, Bruschettini M. Confounding biases in studies on early- versus late-caffeine in preterm infants: a systematic review. Pediatr Res. 2020;88:357–64.
Amaro CM, Bello JA, Jain D, Ramnath A, D’Ugard C, Vanbuskirk S, et al. Early caffeine and weaning from mechanical ventilation in preterm infants: a randomized, placebo-controlled trial. J Pediatr. 2018;196:52–7.
Abu Jawdeh EG, O’Riordan M, Limrungsikul A, Bandyopadhyay A, Argus BM, Nakad PE, et al. Methylxanthine use for apnea of prematurity among an international cohort of neonatologists. J Neonatal Perinatal Med. 2013;6:251–6.
Eichenwald EC, Committee on Fetus and Newborn AAP. Apnea of prematurity. Pediatrics. 2016;137:e20153757.
Chung J, Tran Lopez K, Amendolia B, Bhat V, Nakhla T, Slater-Myer L, et al. Stopping caffeine in premature neonates: how long does it take for the level of caffeine to fall below the therapeutic range? J Matern Fetal Neonatal Med. 2020;1–5: Epub ahead of print.
Doyle J, Davidson D, Katz S, Varela M, Demeglio D, DeCristofaro J. Apnea of prematurity and caffeine pharmacokinetics: potential impact on hospital discharge. J Perinatol. 2016;36:141–4.
Miller MJ, Carlo WA, Martin RJ. Continuous positive airway pressure selectively reduces obstructive apnea in preterm infants. J Pediatr. 1985;106:91–4.
Sreenan C, Lemke RP, Hudson-Mason A, Osiovich H. High-flow nasal cannulae in the management of apnea of prematurity: a comparison with conventional nasal continuous positive airway pressure. Pediatrics. 2001;107:1081–3.
Al-Alaiyan S, Dawoud M, Al-Hazzani F. Positive distending pressure produced by heated, humidified high flow nasal cannula as compared to nasal continuous positive airway pressure in premature infants. J Neonatal Perinatal Med. 2014;7:119–24.
Lemyre B, Davis PG, de Paoli AG. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for apnea of prematurity. Cochrane Database Syst Rev. 2002;1:CD002272.
Pantalitschka T, Sievers J, Urschitz MS, Herberts T, Reher C, Poets CF. Randomised crossover trial of four nasal respiratory support systems for apnoea of prematurity in very low birthweight infants. Arch Dis Child Fetal Neonatal Ed. 2009;94:F245–8.
Gizzi C, Montecchia F, Panetta V, Castellano C, Mariani C, Campelli M, et al. Is synchronised NIPPV more effective than NIPPV and NCPAP in treating apnoea of prematurity (AOP)? A randomised cross-over trial. Arch Dis Child Fetal Neonatal Ed. 2015;100:F17–23.
Tabacaru CR, Moores RR, Khoury J, Rozycki HJ. NAVA-synchronized compared to nonsynchronized noninvasive ventilation for apnea, bradycardia, and desaturation events in VLBW infants. Pediatr Pulmonol. 2019;54:1742–6.
Firestone K, Horany BA, de Leon-Belden L, Stein H. Nasal continuous positive airway pressure versus noninvasive NAVA in preterm neonates with apnea of prematurity: a pilot study with a novel approach. J Perinatol. 2020;40:1211–5.
Quitadamo P, Giorgio V, Zenzeri L, Baldassarre M, Cresi F, Borrelli O, et al. Apnea in preterm neonates: what’s the role of gastroesophageal reflux? A systematic review. Dig Liver Dis. 2020;52:723–9.
Zagol K, Lake DE, Vergales B, Moorman ME, Paget-Brown A, Lee H, et al. Anemia, apnea of prematurity, and blood transfusions. J Pediatr. 2012;161:417–21.e1.
Abu Jawdeh EG, Martin RJ, Dick TE, Walsh MC, Di, Fiore JM. The effect of red blood cell transfusion on intermittent hypoxemia in ELBW infants. J Perinatol. 2014;34:921–5.
Kovatis KZ, Di Fiore JM, Martin RJ, Abbasi S, Chaundhary AS, Hoover S, et al. Effect of blood transfusions on intermittent hypoxic episodes in a prospective study of very low birth weight infants. J Pediatr. 2020;222:65–70.
Kirpalani H, Whyte RK. What is new about transfusions for preterm infants? An update. Neonatology. 2019;115:406–10.
Eichenwald EC, Aina A, Stark AR. Apnea frequently persists beyond term gestation in infants delivered at 24 to 28 weeks. Pediatrics. 1997;100:354–9.
Rhein LM, Dobson NR, Darnall RA, Corwin MJ, Heeren TC, Poets CF, et al. Effects of caffeine on intermittent hypoxia in infants born prematurely: a randomized clinical trial. JAMA Pediatr. 2014;168:250–7.
Dobson NR, Rhein LM, Darnall RA, Corwin MJ, Heeren TC, Eichenwald E, et al. Caffeine decreases intermittent hypoxia in preterm infants nearing term-equivalent age. J Perinatol. 2017;37:1135–40.
Brockmann PE, Wiechers C, Pantalitschka T, Diebold J, Vagedes J, Poets CF. Under-recognition of alarms in a neonatal intensive care unit. Arch Dis Child Fetal Neonatal Ed. 2013;98:F524–7.
Ho T, Dukhovny D, Zupancic JA, Goldmann DA, Horbar JD, Pursley DM. Choosing wisely in newborn medicine: five opportunities to increase value. Pediatrics. 2015;136:e482–9.
Perfect Sychowski S, Dodd E, Thomas P, Peabody J, Clark R. Home apnea monitor use in preterm infants discharged from newborn intensive care units. J Pediatr. 2001;139:245–8.
Strehle EM, Gray WK, Gopisetti S, Richardson J, McGuire J, Malone S. Can home monitoring reduce mortality in infants at increased risk of sudden infant death syndrome? A systematic review. Acta Paediatr. 2012;101:8–13.
Raffay TM, Dylag AM, Sattar A, Abu Jawdeh EG, Cao S, Pax BM, et al. Neonatal intermittent hypoxemia events are associated with diagnosis of bronchopulmonary dysplasia at 36 weeks postmenstrual age. Pediatr Res. 2019;85:318–23.
Fairchild KD, Nagraj VP, Sullivan BA, Moorman JR, Lake DE. Oxygen desaturations in the early neonatal period predict development of bronchopulmonary dysplasia. Pediatr Res. 2019;85:987–93.
Raffay TM, Martin RJ. Intermittent hypoxia and bronchial hyperreactivity. Semin Fetal Neonatal Med. 2020;25:101073.
Darnall RA, Chen X, Nemani KV, Sirieix CM, Gimi B, Knoblach S, et al. Early postnatal exposure to intermittent hypoxia in rodents is proinflammatory, impairs white matter integrity, and alters brain metabolism. Pediatr Res. 2017;82:164–72.
Poets CF, Roberts RS, Schmidt B, Whyte RK, Asztalos EV, Bader D, et al. Association between intermittent hypoxemia or bradycardia and late death or disability in extremely preterm infants. JAMA. 2015;314:595–603.
Gozal D. Sleep-disordered breathing and school performance in children. Pediatrics. 1998;102:616–20.
Hunt CE. Neurocognitive outcomes in sleep-disordered breathing. J Pediatr. 2004;145:430–2.
Janvier A, Khairy M, Kokkotis A, Cormier C, Messmer D, Barrington KJ. Apnea is associated with neurodevelopmental impairment in very low birth weight infants. J Perinatol. 2004;24:763–8.
Greene MM, Patra K, Khan S, Karst JS, Nelson MN, Silvestri JM. Cardiorespiratory events in extremely low birth weight infants: neurodevelopmental outcome at 1 and 2 years. J Perinatol. 2014;34:562–5.
Pillekamp F, Hermann C, Keller T, von Gontard A, Kribs A, Roth B. Factors influencing apnea and bradycardia of prematurity - implications for neurodevelopment. Neonatology. 2007;91:155–61.
Tieder JS, Bonkowsky JL, Etzel RA, Franklin WH, Gremse DA, Herman B, et al. Brief resolved unexplained events (formerly apparent life-threatening events) and evaluation of lower-risk infants. Pediatrics. 2016;137:e20160590.
DeLaroche AM, Haddad R, Farooqi A, Sapién RE, Tieder JS. Outcome prediction of higher-risk brief resolved unexplained events. Hosp Pediatr. 2020;10:303–10.
Moon RY, Task Force on Sudden Infant Death Syndrome. SIDS and other sleep-related infant deaths: evidence base for 2016 updated recommendations for a safe infant sleeping environment. Pediatrics. 2016;138:e20162940.
Malloy MH. Prematurity and sudden infant death syndrome: United States 2005–2007. J Perinatol. 2013;33:470–5.
Di Fiore JM, MacFarlane PM, Martin RJ. Intermittent hypoxemia in preterm infants. Clin Perinatol. 2019;46:553–65.
Chen T, Hughes ME, Wang H, Wang G, Hong X, Liu L, et al. Prenatal, perinatal, and early childhood factors associated with childhood obstructive sleep apnea. J Pediatr. 2019;212:20–7.e10.
Thomas B, Thillainathan K, Delahunty M, Weichard A, Davey MJ, Nixon GM, et al. Cardiovascular autonomic control is altered in children born preterm with sleep disordered breathing. J Pediatr. 2019;206:83–90.
Tapia IE, Marcus CL, McDonough JM, Kim JY, Cornaglia MA, Xiao R, et al. Airway resistance in children with obstructive sleep apnea syndrome. Sleep. 2016;39:793–9.
Huang YS, Hsu JF, Paiva T, Chin WC, Chen IC, Guilleminault C. Sleep-disordered breathing, craniofacial development, and neurodevelopment in premature infants: a 2-year follow-up study. Sleep Med. 2019;60:20–5.
Hibbs AM, Johnson NL, Rosen CL, Kirchner HL, Martin R, Storfer-Isser A, et al. Prenatal and neonatal risk factors for sleep disordered breathing in school-aged children born preterm. J Pediatr. 2008;153:176–82.
Amin SB, Burnell E. Monitoring apnea of prematurity: validity of nursing documentation and bedside cardiorespiratory monitor. Am J Perinatol. 2013;30:643–8.
Mathew OP. Apnea of prematurity: pathogenesis and management strategies. J Perinatol. 2011;31:302–10.
Di Fiore JM, Poets CF, Gauda E, Martin RJ, MacFarlane P. Cardiorespiratory events in preterm infants: interventions and consequences. J Perinatol. 2016;36:251–8.
Kraaijenga JV, Hutten GJ, de Waal CG, de Jongh FH, Onland W, van Kaam AH. Classifying apnea of prematurity by transcutaneous electromyography of the diaphragm. Neonatology. 2018;113:140–5.
Williamson JR, Bliss DW, Paydarfar D. Forecasting respiratory collapse: theory and practice for averting life-threatening infant apneas. Respir Physiol Neurobiol. 2013;189:223–31.
Coughlin K, Posencheg M, Orfe L, Zachritz W, Meadow J, Yang K, et al. Reducing variation in the management of apnea of prematurity in the intensive care nursery. Pediatrics. 2020;145:e20190861.
Alvaro RE, Khalil M, Qurashi M, Al-Saif S, Al-Matary A, Chiu A, et al. CO(2) inhalation as a treatment for apnea of prematurity: a randomized double-blind controlled trial. J Pediatr. 2012;160:252–7.e1.
Joseph LJ, Goldberg S, Picard E. CO2 treatment for apnea. J Pediatr. 2009;154:627–8. author reply 8-9
Ballout RA, Foster JP, Kahale LA, Badr L. Body positioning for spontaneously breathing preterm infants with apnoea. Cochrane Database Syst Rev. 2017;1:CD004951.
Gaugler C, Marlier L, Messer J. Sensory stimulations for the treatment of idiopathic apneas of prematurity. Arch Pediatr. 2007;14:485–9.
Cramer SJE, Dekker J, Dankelman J, Pauws SC, Hooper SB, Te, Pas AB. Effect of tactile stimulation on termination and prevention of apnea of prematurity: a systematic review. Front Pediatr. 2018;6:45.
Henderson-Smart DJ, Osborn DA. Kinesthetic stimulation for preventing apnea in preterm infants. Cochrane Database Syst Rev. 2002;2:CD000373.
Kesavan K, Frank P, Cordero DM, Benharash P, Harper RM. Neuromodulation of limb proprioceptive afferents decreases apnea of prematurity and accompanying intermittent hypoxia and bradycardia. PLoS ONE. 2016;11:e0157349.
Marlier L, Gaugler C, Messer J. Olfactory stimulation prevents apnea in premature newborns. Pediatrics. 2005;115:83–8.
Montealegre-Pomar A, Bohorquez A, Charpak N. Systematic review and meta-analysis suggest that Kangaroo position protects against apnoea of prematurity. Acta Paediatr. 2020;109:1310–6.
Vliegenthart RJ, Ten Hove CH, Onland W, van Kaam AH. Doxapram treatment for apnea of prematurity: a systematic review. Neonatology. 2017;111:162–71.
Terrin G, Passariello A, De Curtis M, Manguso F, Salvia G, Lega L, et al. Ranitidine is associated with infections, necrotizing enterocolitis, and fatal outcome in newborns. Pediatrics. 2012;129:e40–5.
Bairam A, Boukari R, Joseph V. Targeting progesterone receptors in newborn males and females: from the animal model to a new perspective for the treatment of apnea of prematurity? Respir Physiol Neurobiol. 2019;263:55–61.
Ren J, Ding X, Greer JJ. Ampakines enhance weak endogenous respiratory drive and alleviate apnea in perinatal rats. Am J Respir Crit Care Med. 2015;191:704–10.
Saroha V, Patel RM. Caffeine for preterm infants: fixed standard dose, adjustments for age or high dose? Semin Fetal Neonatal Med. 2020;25:101178.
Davis PG. When to start and stop caffeine and why respiratory status matters. Semin Fetal Neonatal Med. 2020;25:101175.
Author information
Authors and Affiliations
Contributions
All authors were involved in the design of included content, review of the recent literature, development of tables and figures, and the writing of the paper.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests. The views expressed in this review do not reflect the official policy or position of the United States Air Force, Army, Navy, Department of Defense, or the U.S. Government.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Erickson, G., Dobson, N.R. & Hunt, C.E. Immature control of breathing and apnea of prematurity: the known and unknown. J Perinatol 41, 2111–2123 (2021). https://doi.org/10.1038/s41372-021-01010-z
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41372-021-01010-z
This article is cited by
-
Early aminophylline is a potential therapy for preventing bronchopulmonary dysplasia in premature infants: a retrospective study
BMC Pediatrics (2025)
-
Electrical impedance tomography in neonates: a review
Pediatric Research (2025)
-
Definitions and monitoring methods for apnea in preterm infants: a scoping review
Pediatric Research (2025)
-
Congenital extraventricular neurocytoma with atypical features in a 3-day-old neonate
Child's Nervous System (2025)
-
Deep sedation in lateral position for preterm infants during cerebral magnetic resonance imaging: a pilot study
Journal of Anesthesia, Analgesia and Critical Care (2024)


